The National Rugby League has revealed major sponsor Telstra demanded “tough action” after the so-called “Summer of Hell” of player scandals, as it attempts to defend its no fault stand-down rule in an appeal launched by Dragons player Jack de Belin challenging his suspension.
A class action has been filed against a NSW state government-controlled entity over Sydney’s scandal-plagued Opal Tower, in a claim that is expected to seek millions of dollars of compensation on behalf of hundreds of apartment owners.
Ex-Tennis Australia director Harold Mitchell, facing enforcement action by ASIC alleging he breached his duties in awarding Australian Open broadcast rights to the Seven Network, has asked a court for all evidence the regulator obtained from former board member Graeme Holloway, who died in February.
A judge has given the all-clear to an investment management company to access evidence for potential legal action against the National Stock Exchange of Australia after the firm’s shares were suspended without warning or explanation.
Rural supply giant Landmark’s has offered to sell three stores to win Australian Competition and Consumer Commission approval for its proposed $469 million takeover of competitor Ruralco, a move that would consolidate two of the three largest players in the rural merchandise market.
A claim by Coles for $40 million in tax credits for fuel that evaporates or leaks from the 3,000 tanks at its service stations — based on an argument that the company buys extra fuel to account for the loss — is “completely unreal”, a lawyer for the tax office told a court Monday.
One of the top executives of MediaCom has filed a lawsuit against the media agency claiming he was fired and also passed up for promotion after requesting flexible working arrangements to accommodate his worsening depression.
The Australian Competition and Consumer Commission has appealed a Federal Court judgment tossing its consumer case against Kimberly-Clark over “flushable” wipes.
Korean drug company Samsung Bioepis has filed a lawsuit seeking to invalidate German drug company Fresenius Kadi’s patent for a biosimilar of blockbuster arthritis drug Humira.
A judge has discontinued a class action brought against a Queensland law firm over allegedly non-compliant conditional costs agreements, after finding no evidence that anyone other than the lead plaintiff was interested in bringing a claim.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
